CVE-2008-0474

Description

Multiple cross-site scripting (XSS) vulnerabilities in ManageEngine Applications Manager 8.1 build 8100 allow remote attackers to inject arbitrary web script or HTML via the (1) showlink parameter to jsp/DiscoveryProfiles.jsp; the (2) attributeIDs, (3) attributeToSelect, (4) redirectto, and (5) resourceid parameters to (a) jsp/ThresholdActionConfiguration.jsp; the (6) page and (7) redirect parameters to (b) jsp/UpdateGlobalSettings.jsp; and the (8) haid and (9) returnpath parameters to (c) showTile.do. NOTE: the provenance of this information is unknown; the details are obtained solely from third party information.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.30%
Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.securityfocus.com/bid/27443 vdb entry
http://secunia.com/advisories/28332 third party advisory vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/39914 vdb entry

Frequently Asked Questions

What is the severity of CVE-2008-0474?
CVE-2008-0474 has been scored as a medium severity vulnerability.
How to fix CVE-2008-0474?
To fix CVE-2008-0474, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2008-0474 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2008-0474 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.